Given that members of the Bcl-2 family of proteins are involved in the regulation of tumor-induced apoptosis in DCs derived in vitro [7], we examined whether protection from TDSN-induced apoptosis could be mediated by modulation of the expression of the anti-apoptotic protein Bcl-2. This evidence concerns the gene BCL2 and neoplasm.